Cep55/c10orf3, a Tumor Antigen Derived From a Centrosome Residing Protein in Breast Carcinoma-Reference-Cited by-同舟云学术

Cep55/c10orf3, a Tumor Antigen Derived From a Centrosome Residing Protein in Breast Carcinoma

Published:2009-06 Issue:5 Volume:32 Page:474-485
ISSN:1524-9557
Container-title:Journal of Immunotherapy
language:en
Short-container-title:

Author:

Inoda Satoko,Hirohashi Yoshihiko,Torigoe Toshihiko,Nakatsugawa Munehide,Kiriyama Kenji,Nakazawa Emiri,Harada Kenji,Takasu Hideo,Tamura Yasuaki,Kamiguchi Kenjiro,Asanuma Hiroko,Tsuruma Tetsuhiro,Terui Takeshi,Ishitani Kunihiko,Ohmura Tosei,Wang Qiang,Greene Mark I.,Hasegawa Tadashi,Hirata Koichi,Sato Noriyuki

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology,Immunology,Immunology and Allergy

Reference28 articles.

1. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma;van der Bruggen;Science,1991

2. Human T cell responses against melanoma;Boon;Annu Rev Immunol,2006

3. Progress in human tumour immunology and immunotherapy;Rosenberg;Nature,2001

4. The centrosome in normal and transformed cells;Wang;DNA Cell Biol,2004

5. Oncogenes and tumour suppressors take on centrosomes;Fukasawa;Nat Rev Cancer,2007

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinicopathological and prognostic role of CEP55 expression in cancer patients: A meta‐analysis of 31 studies with 12,543 patients;iLABMED;2024-08-19

2. N6‐methyladenosine‐mediated LINC01087 promotes lung adenocarcinoma progression by regulating miR‐514a‐3p to upregulate centrosome protein 55;The Kaohsiung Journal of Medical Sciences;2024-07-18

3. DNAJB8 oligomerization is mediated by an aromatic-rich motif that is dispensable for substrate activity;Structure;2024-06

4. Molecular Pathogenic Mechanisms of IgA Nephropathy Secondary to COVID-19 mRNA Vaccination;Kidney and Blood Pressure Research;2024-02-01

5. Centrosomal Protein 55 (CEP55) Drives Immune Exclusion and Resistance to Immune Checkpoint Inhibitors in Colorectal Cancer;Vaccines;2024-01-08